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ABSTRACT. We investigated a possible association between 
alcoholism, cigarette smoking, obesity and CYP2E1 RsaI and 96-bp 
insertion genetic polymorphisms with risk for colorectal cancer (CRC). 
Patients with CRC (70 women and 61 men) were matched for gender 
and age to 206 healthy controls. The mean age of the two groups was 
62 years. Meat intake, cigarette smoking and alcohol drinking were 
assessed using a specific frequency questionnaire. The body mass index 
was also calculated. DNA was extracted from peripheral blood; RsaI 
polymorphism genotypes were evaluated by PCR-RFLP and 96-bp 
insertion genetic polymorphisms were evaluated by specific primers. 
The distributions of CYP2E1 RsaI c1/c1, c1/c2 and c2/c2 genotypes were 
90.2, 9.2 and 0.6%, respectively, in controls and 83.9, 13.7 and 2.4% in 
CRC cases. Allele c2 was associated with increased risk for CRC [odds 
ratio (OR) = 1.88, 95% confidence interval (95%CI) = 1.02-3.45]. The 
CYP2E1 RsaI c2/c2 genotype was associated with an increased risk 
for rectal cancer (OR = 3.23, 95%CI = 1.26-9.03). The 96-bp insertion 
was slightly more frequent in the CRC group (9.3 vs 11.4%, P = 0.19), 
especially in females (6.4 vs 11.5%, P = 0.34). Smoking, alcohol 
drinking or high intake of red meat and CYP2E1 polymorphisms were 
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not associated with increased risk for CRC. The 96-bp insertion was 
marginally more frequent (P = 0.07) in undernourished CRC subjects. 
We concluded that the risk for CRC is higher among individuals with 
allele c2. The CYP2E1 RsaI c2/c2 genotype was associated with an 
increased risk for rectal cancer.
Key words: CYP2E1; Polymorphism; Colorectal cancer
INTRODUCTION
Colorectal cancer (CRC) is one of the most common cancers in the world. The Brazil-
ian Institute of Cancer (INCA) estimated that 13,310 men and 14,800 women had been newly 
diagnosed with CRC in Brazil during 2010. These values correspond to an estimated risk of 14 
and 15 new cases per 100,000 men and women, respectively (INCA, 2011).
Epidemiological studies have identified dietary factors, such as consumption of meat, 
especially red meat, and cigarette smoking as possible risk factors for the development of 
CRC (Le-Marchand et al., 2002; Küry et al., 2007). Obesity and low physical activity have 
also been associated with a higher incidence of this cancer (Reszka et al., 2006). Dietary car-
cinogens, radiation, and nicotine tend to promote chromosome instability, while dietary fiber, 
minerals, and vitamins tend to normalize the cell cycle (Ferreira and Rocha, 2004).
Several carcinogens require metabolic activation by enzymes to exert their genotoxic 
effects, and inherited variations in genes associated with the metabolization of carcinogens 
may result in altered enzyme activity and, subsequently, carcinogen activation or deactivation. 
Phase I enzymes, including cytochrome P450 (CYP), activate several compounds to form 
genotoxic electrophilic intermediates (Boccia et al., 2007; Neafsey et al., 2009).
CYP2E1, a member of the cytochrome P450 superfamily, is a naturally occurring 
ethanol- and obesity-inducible enzyme that is primarily responsible for the metabolic acti-
vation of many low molecular weight carcinogens, such as N-nitrosamines, aniline, vinyl 
chloride, urethane, and alcohol (Knodell et al., 1991). N-nitrosamines present in tobacco and 
diet are well-recognized carcinogens involved in the development of tumors at various sites. 
Functional CYP2E1 gene polymorphisms might, therefore, impact on susceptibility to cancer 
development (Gao et al., 2007).
Among the known genetic polymorphisms in the CYP2E1 gene, the RsaI variant cor-
responding to a C-1054T substitution (rs2031920) and the 96-bp insertion in the 5'-flanking 
region have drawn much interest because of their potential functionality. According to the con-
ventional nomenclature, the RsaI wild-type allele (commonly called c1 allele) and the variant 
c2 allele correspond to CYP2E1*5A and CYP2E1*5B, respectively. The insertion allele in the 
96-bp region is named CYP2E1*1D, whereas the noninsertion allele is CYP2E1*1C (Morita 
et al., 2009).
Few studies have focused on the role of RsaI polymorphism in the pathogenesis of 
cancers of the colon and rectum, lung, head and neck, bladder, nasopharynx, and stomach, and 
their results have been inconsistent. The reasons for this discrepancy are not clear, but one 
problem is the lack of sufficient investigation of gene environmental interactions, including 
links with dietary and smoking habits and environmental factors that may alter the enzyme 
activity of CYP2E1 and thereby modify cancer susceptibility due to CYP2E1 polymorphisms 
3140
©FUNPEC-RP www.funpecrp.com.brGenetics and Molecular Research 11 (3): 3138-3145 (2012)
T.D. Silva et al.
(Gao et al., 2007; Masuda et al., 2007; Morita et al., 2009; Jia et al., 2009; Wang et al., 2010; 
Cantor et al., 2010; Lu et al., 2011).
The aim of the present study was to investigate CYP2E1 polymorphisms in Brazilian 
patients from São Paulo.
MATERIAL AND METHODS
A case-control study involving 131 patients with CRC and 206 healthy subjects was 
carried out between March 2008 and December 2010. We recruited CRC cases that were man-
aged by the Oncology Group, Gastroenterology Division of the Universidade Federal de São 
Paulo. All the recruited patients were histopathologically diagnosed with colorectal adenocar-
cinoma. Controls were selected from cancer-free individuals selected during a routine check-
up by the Central Laboratory of the Universidade Federal de São Paulo. Eligibility criteria 
for the controls were as follows: no prior diagnosis of colorectal cancer; age between 18 and 
74 years at the time of selection, and history of partial or total removal of the CRC, familial 
adenomatous polyposis, or inflammatory bowel disease. The study was approved by the local 
Ethics Committee, and all patients provided written informed consent.
The patients answered a structured questionnaire regarding dietary habits and fre-
quency of red meat intake, whether they were current or former cigarette smokers, and pat-
tern of alcohol consumption. Smokers were divided into 2 groups - never and ever smokers 
(current and former). Drinkers also were divided into 3 groups (≥3 times/week, <3 times/
week, and no drinking) according to drinking frequency. Subjects were also divided into 3 
groups according to the frequency of red meat intake (≥3 times/week, <3 times/week, and no 
red meat intake). Anthropometric questions inquired about height (cm) and body weight (kg) 
in the current year. Body mass index (BMI; kg/m2) was analyzed for subjects in each case 
group. According to the BMI, the subjects were classified into 3 groups: undernourished, well-
nourished, and overweight.
Peripheral blood was collected for genomic DNA extraction. CYP2E1 gene polymor-
phisms were investigated by the polymerase chain reaction (PCR)-restriction fragment length 
polymorphism (RFLP) genotyping technique.
DNA extraction
Leukocyte DNA was extracted from peripheral venous blood collected in EDTA tubes 
by using the Invisorb® Spin Blood Mini kit.
Analysis of CYP2E1 genetic polymorphisms
The genotypes of the CYP2E1 polymorphism were analyzed as described previous-
ly (Morita et al., 2009). Genotyping for the CYP2E1 RsaI polymorphism was determined 
by the PCR-RFLP using the primers 5'-CCAGTCGAGTCTACATTGTCA-3' (forward) and 
5'-TTCATTCTGTCTTCTAACTGG-3' (reverse). The PCR product of 413 bp in length was 
digested by treatment with 5 U RsaI for 1 h at 37°C. The digestion resulted in fragments of 352 
and 61 bp for the c1 allele. The digested fragments were electrophoresed on a 3% agarose LE 
(Uniscience) gel and visualized using ethidium bromide.
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The 96-bp insertion genotype was identified by the PCR method, as described previ-
ously, by using the primers 5'-GTGATGGAAGCCTGAAGAACA-3' (forward) and 5'-TTTGG
TGGGGTGAGAACAG-3' (reverse). The fragments were electrophoresed on a 3% agarose 
LE (Uniscience) gel and visualized using ethidium bromide. The PCR products of the 96-bp 
insertion allele and non-insertion allele were 729 and 633 bp in length, respectively. Genotyp-
ing was routinely repeated if there was any uncertainty in determining the genotype.
Statistical analysis
The Student t-test was used for the comparison of age between the groups. Differences 
in the polymorphisms between the groups were determined by the chi-square test. This test 
was also used to compare the clinical variables between the CYP2E1 genotypes and alleles in 
the cancer patients. The association between the risk of developing cancer and these variables 
was assessed by calculating the odds ratio (OR) and 95% confidence interval (95%CI). A P 
value of <0.05 was considered to be statistically significant, and a P value of 0.05 to 0.10 was 
considered to be marginally significant.
RESULTS
A case-control study was conducted on 131 CRC patients and 206 healthy controls 
to determine whether the CYP2E1 genetic polymorphisms RsaI and 96-bp insertion are as-
sociated with the development of this disease. The characteristics of the cancer patients and 
controls are shown in Table 1. No difference in age or gender was observed between the 
groups. Among the 131 cancer patients, 83 (63.3%) had colon cancer and 48 (36.7%) had 
rectal cancer. According to the TNM classification, most patients were at stage II (43.5%) or 
III (25.1%) of cancer.
      Patients [N (%)]     Control [N (%)] P
Parameters
Age, years (±SD)       62.4 (13.6)       61.7 (13.3)  0.67a
   ≤50    25 (19.0)    31 (15.1) 
   >50  106 (81.0)  175 (84.9) 
Gender
   Male    61 (46.5)    82 (39.8)  0.267b
   Female    70 (53.5)  124 (60.2) 
Tumor site
   Colon    83 (63.3)  
   Rectum    48 (36.7)  
Stage
   I    21 (16.0)  
   II    57 (43.5)  
   III    33 (25.1)  
   IV    20 (15.4)
at-test; bχ2 test.
Table 1. Characteristics of the patients.
The distributions of the c1/c1, c1/c2, and c2/c2 genotypes of CYP2E1 RsaI were 90.2, 
9.2, and 0.6%, respectively, in the controls, and 83.9, 13.7, and 2.4% in the CRC patients (Ta-
ble 2). Among the healthy control subjects, the observed genotype frequencies of the CYP2E1 
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polymorphisms were consistent with the frequency expected under the Hardy-Weinberg equi-
librium (P = 0.50 for RsaI and P = 0.48 for 96-bp insertion), which suggested that the distribu-
tion of the CYP2E1 genotypes is adequate in the cancer-free population.
Genotype  All individuals  P   Female  P   Male P
 Control [N (%)] Case [N (%)]  Control [N (%)] Cancer [N (%)]  Control [N (%)] Cancer [N (%)]
RsaI
   c1/c1 186 (90.2) 110 (83.9) 0.13 112 (90.3) 59 (84.2) 0.35 74 (90.2) 51 (83.6) 0.32
   c1/c2 19 (9.2)   18 (13.7)  11 (8.8)   9 (12.8)  8 (9.8)   9 (14.7) 
   c2/c2   1 (0.6)   3 (2.4)    1 (0.9) 2 (3.0)  0 1 (1.7) 
96-bp isertion
   0 187 (90.7) 116 (88.6) 0.19 116 (93.6) 62 (88.5) 0.34 71 (86.6) 54 (88.5) 0.16
   1 19 (9.3) 13 (9.9)    8 (6.4)   8 (11.5)  11 (13.4) 5 (8.1) 
   2 0   2 (1.5)  0 0  0 2 (3.1) 
   1 or 2 19 (9.3)   15 (11.4)    8 (6.4)   8 (11.5)  11 (13.4)   7 (11.4)
Table 2. CYP2E1 polymorphisms RsaI and 96-bp insertion in all the individuals and according to genders.
According to the site, the distributions of the genotypes c1/c1, c1/c2, and c2/c2 were 
89.1, 8.4, and 2.5% respectively, in colon cancer cases, and 75.0, 22.9 and 2.1% in rectal can-
cer patients (Table 3). The allele c2 was more frequent in the CRC patients, which indicates 
that its presence is associated with an increased risk of CRC (P = 0.05; OR = 1.88, 95%CI = 
1.02-3.45; Table 4). The c2/c2 genotype of CYP2E1 RsaI was associated with a high risk of 
rectal cancer (P = 0.06; OR = 3.23, 95%CI = 1.26-9.03), but not colon cancer (Table 4).
Genotype  All individuals  P   Female  P   Male  P
 Colon [N (%)] Rectum [N (%)]  Colon [N (%)] Rectum [N (%)]  Colon [N (%)] Rectum [N (%)]
c1/c1 74 (89.1) 36 (75.0) 0.06 39 (86.6) 20 (80.0) 0.25 35 (92.1) 16 (69.5) 0.05
c1/c2 7 (8.4) 11 (22.9)  4 (8.8)   5 (20.0)  3 (7.9)   6 (26.0)
c2/c2 2 (2.5) 1 (2.1)  2 (4.6) 0  0 1 (4.5)
Table 3. CYP2E1 RsaI polymorphisms according to the site.
With regard to the 96-bp insertion polymorphism of CYP2E1, non-insertion of 96 bp 
was more frequent in both groups, with the frequency being 90.7 in the colon cancer cases and 
88.6 in the controls. The genotype frequencies of the 96-bp insertion polymorphism did not 
differ between the cases and controls, but it was slightly more frequent in the CRC group (11.5 
Allele Control [N (%)] Cancer [N (%)] P OR 95%CI
   c1 391 (94.9) 238 (90.8) 0.05 1.88 1.02-3.45
   c2 21 (5.1) 24 (9.2)
CYP2E1 genotype Colon [N (%)] Rectum [N (%)]
   c1/c1   74 (89.1)   36 (75.0)
   c1/c2   7 (8.4)   11 (22.9) 0.06 3.23 1.16-9.03
   c2/c2   2 (2.5)   1 (2.1)
Table 4. Allele frequency RsaI polymorphism in both groups and in colon or rectal cancer.
OR = odds ratio; 95%CI = confidence interval at 95%.
3143
©FUNPEC-RP www.funpecrp.com.brGenetics and Molecular Research 11 (3): 3138-3145 (2012)
CYP2E1 RsaI c2/c2 genotype associated with CRC
vs 6.4%, P = 0.34), especially among female subjects (Table 2).
The polymorphisms studied were not associated with cigarette smoking, alcohol 
drinking, or red meat intake and risk of colorectal cancer for RsaI polymorphism [OR = 2.11, 
95%CI = 0.74-6.03; OR = 1.39, 95%CI = 0.61-3.15, OR = 1.58, 95%CI = 0.69-3.65, respec-
tively], and for CYP2E1 96-bp insertion polymorphism [OR = 1.23, 95%CI = 0.36-4.23; OR 
= 1.11, 95%CI = 0.47-2.61, OR = 0.93, 95%CI = 0.38-2.28].
Undernourished subjects had a marginally higher frequency of the 96-bp insertion (P 
= 0.07). In CYP2E1 RsaI polymorphism, no difference was found among individuals and BMI 
(P = 0.44; Table 5).
Genotype Under and well nourished Overweight  P Overweight  Under nourished  P
 [N (%)] [N (%)]  [N (%)] [N (%)]
96-bp insertion  61 67   67 13
   0 53 (86.8) 60 (89.5)   0.32 60 (89.5) 11 (84.6) 0.07
   1 6 (9.8)   7 (10.5)    7 (10.5) 1 (7.7)
   2 2 (3.4) 0  0 1 (7.7)
   1 or 2   8 (13.2)   7 (10.5)    7 (10.5)   2 (15.4)
RsaI genotype  61 67  67 13
   c1/c1 51 (83.6) 56 (83.5) 0.2 56 (83.5) 10 (76.9) 0.44
   c1/c2 10 (16.4)   8 (11.9)    8 (11.9)   3 (23.1)
   c2/c2 0 3 (4.6)  3 (4.6) 0
Table 5. Genotypes of individuals in the colorectal cancer group and body mass index.
DISCUSSION
CRC is the third and the second most common cancer worldwide in men and women, 
respectively. Almost 60% of the cases occur in developed regions. About 608,000 deaths from 
CRC are estimated worldwide, accounting for 8% of all cancer deaths, making it the fourth 
most common cause of death from cancer (Ferlay et al., 2010).
Among the patients studied, most of them were women (53.5%), and the mean age 
was 62.4 years. These findings agree with the data published by the Brazilian National Cancer 
Institute (INCA, 2011).
Variations in the frequency of the CYP2E1 genotypes among different populations 
and ethnic groups have been reported in several studies carried out in different regions of the 
world. These variations may be attributable to differences in race and lifestyle of the subjects 
and also to the differences in the techniques adopted by the studies.
A meta-analysis performed by Zhou et al. (2010), which examined 10 other case-
control studies based on Caucasian and Asian populations, indicated a higher risk for CRC 
in individuals homozygous c2/c2 genotype of CYP2E1 RsaI. Another study in a Hungarian 
population also found an association between the c2 allele and increased susceptibility to CRC 
(Kiss et al., 2000). The c2 allele has been associated with increased cancer risk in the case of 
head and neck tumors (Tang et al., 2010), but has been found to serve as a protective factor in 
the case of lung cancer (Zhan et al., 2010).
In this study, the c2 allele polymorphism of CYP2E1 was found to be more frequent in 
CRC patients, suggesting a statistically significant increase in the risk of developing CRC (P = 
0.05, OR = 1.88, 95%CI = 1.02-3.45). The genotypes c2/c2 and c1/c2 were more common in 
patients with tumors of the rectum (OR = 3.23, 95%CI = 1.16-9.03).
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Hayashi et al. (1991) found a 10-fold higher transcriptional activity of the c2/c2 al-
lele of CYP2E1 than the c1/c1 allele in the HepG2 cell line, suggesting that the transcriptional 
activity of c2 allele must be larger that of c1. This overexpression may be partially mediated 
by the c2 allele rendering the individual more susceptible to CRC.
Morita et al. (2009) reported a higher risk of CRC in patients with the genetic poly-
morphisms of CYP2E1 in the 96-bp insertion allele. In this study, the absence of the 96-bp in-
sertion allele was more frequent in both case and control groups, and although not statistically 
significant, the 96-bp insertion allele was more frequent in the CRC patients, especially those 
of the female gender, suggesting a possible association with an increased risk of developing 
cancer if a larger number of participants were studied.
Studies have shown that the activity of CYP2E1 may be modulated by alcohol drink-
ing, smoking, diet, and obesity (Ginsberg et al., 2009). However, many studies have failed to 
find associations between genetic polymorphisms, lifestyle habits, diet, and the risk of devel-
oping cancer. A possible reason for this lack of significance is the lack of association between 
external factors, such as diet, alcohol consumption, smoking, and obesity, and genetic factors.
This study examined alcohol consumption, smoking, and red meat intake, and we 
did not find any association between these aspects, the CYP2E1 RsaI polymorphism or 96-bp 
insertion allele, and risk of cancer.
BMI-based classification of the subjects revealed that the 96-bp insertion allele was 
marginally more frequent in overweight individuals (P = 0.07). This is a very interesting find-
ing, since the 96-bp insertion allele was slightly more frequent in the case group, and the 
activity of CYP2E1 is known to be modulated by obesity. Larger studies are needed to confirm 
whether the presence of the 96-bp insertion increases the susceptibility of obese subjects to 
CRC. No association was noted between the CYP2E1 RsaI polymorphism and BMI.
Carcinogenesis is a slow and gradual process, which involves several genetic and 
environmental factors. Biometabolism enzymes, both of phase I and phase II, are key to the 
metabolic processes of our body, and are therefore of fundamental importance. Effective de-
toxification and/or activation of xenobiotics depend on the correct functioning of these en-
zymes. Genetic polymorphisms in biometabolism enzymes, such as CYP2E1, render individu-
als more susceptible to CRC due to a malfunction in enzymatic processes.
In summary, the risk of CRC was higher among individuals with the allele c2. The 
CYP2E1 RsaI c2/c2 genotype was associated with an increased risk of rectal cancer. The 96-bp 
insertion did not increase the risk of colorectal cancer.
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